First ever in Indian diagnostics industry: Neuberg Diagnostics secures Rs 940 crores from Kotak Alt

New Delhi: Neuberg Diagnostics has secured Rs 940 crores from Kotak Alt in the largest-ever primary fund-raise in the Indian diagnostics sector.

Neuberg Diagnostics, founded in 2017 and headquartered in Chennai, has rapidly emerged as the fastest-growing, largest integrated diagnostics player in the country.

Speaking about the fundraise, Dr GSK Velu, Founder and MD of Neuberg Diagnostics, said, “This funding will enable us to enhance our capabilities in the areas of personalized medicine, integrated diagnostics and inorganically expand our footprint across the country. As we prepare for an IPO, we remain committed to making high-quality diagnostics accessible to all, ensuring that our services continue to meet the evolving needs of clinicians and patients.”

The company has an extensive network spanning over 10,000 touch points and 250+ labs across 250 cities. It boasts a highly skilled team of clinical pathologists, oncopathologists, biochemists, geneticists, and other certified lab professionals, giving it the capability to perform over 5,000 types of tests. Additionally, Neuberg ranks as one of the top 2 genomics players in India and holds a leadership position in newborn screening & reproductive genomics testing.

Rahul Shah, Partner at Kotak Alt said, “We are excited to partner with Neuberg Diagnostics as they work to transform the diagnostics landscape in India. The investment reflects our confidence in Neuberg’s vision and potential. We are confident that this strategic investment will play a key role in increasing the scale of Neuberg Diagnostics and help the Company get ready for their upcoming IPO. This investment solidifies our commitment to supporting quality healthcare solutions that improve patient outcomes and accessibility.”

o3 Capital acted as the exclusive financial advisor to Neuberg Diagnostics for their fundraise from Kotak Alt.